Related Experiment Video
Updated: May 10, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis
I J Chan1, S Kasprowicz, M D Tharp
1Department of Dermatology, Rush University Medical Center, Chicago, IL, USA. ichan@rush.edu
Background:
The activating mutations KIT(V560G) and KIT(D816V) are associated with mastocytosis. Thus, identifying and inhibiting the signalling pathways associated with mutated KIT gene offers a potentially important strategy for the treatment of mastocytosis.
Aim:
To correlate KIT mutations with specific signalling pathways in human mast-cell lines using pathway inhibitors.
Methods:
Human mast-cell (HMC) lines expressing KIT(V560G) (the cell line HMC-1) and KIT(V560G and D816V) (HMC-1.2) were treated with specific signalling pathway inhibitors for 1-5 days, and the inhibitory effects on growth were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell-proliferation assay, western blotting and flow cytometry.
Results:
Growth inhibitory assays and western blot analyses showed that the Janus kinase 3/signal transducer and activator of transcription (JAK3/STAT) pathway is the preferential signalling pathway for KIT(V560G), whereas the mechanistic target of rapamycin complex 1/4E-binding protein 1 (mTORC1/4E-BP1) pathway is preferentially linked to KIT(D816V). Inhibition of these critical signalling pathways results in programmed cell death.
Conclusions:
KIT(V560G) and KIT(D816V) use different signalling pathways that promote mast-cell growth. Inhibitors of these specific pathways might be effective in treating mastocytosis.
Insights
Activating KIT mutations in mastocytosis utilize distinct signaling pathways. KIT(V560G) activates JAK3/STAT, while KIT(D816V) activates mTORC1. Inhibiting these pathways induces cell death, offering new mastocytosis treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Activating mutations in the KIT gene, specifically KIT(V560G) and KIT(D816V), are strongly associated with mastocytosis.
- Targeting signaling pathways downstream of mutated KIT presents a promising therapeutic strategy for mastocytosis.
Purpose of the Study:
- To investigate and correlate specific KIT mutations with their associated signaling pathways in human mast cell lines.
- To utilize pathway inhibitors to elucidate the functional roles of these pathways in mastocytosis.
Main Methods:
- Human mast cell lines (HMC-1 and HMC-1.2) expressing KIT(V560G) and dual KIT(V560G)/KIT(D816V) mutations were treated with specific pathway inhibitors.
- Cell proliferation was assessed using MTT assays, and protein expression/pathway activation was analyzed via western blotting and flow cytometry.
Main Results:
- The Janus kinase 3/signal transducer and activator of transcription (JAK3/STAT) pathway was identified as the primary pathway for KIT(V560G).
- The mechanistic target of rapamycin complex 1/4E-binding protein 1 (mTORC1/4E-BP1) pathway was found to be preferentially linked to KIT(D816V).
- Inhibition of these identified pathways led to programmed cell death in mast cells.
Conclusions:
- KIT(V560G) and KIT(D816V) mutations activate distinct signaling cascades that drive mast cell proliferation.
- Targeted inhibition of the JAK3/STAT pathway for KIT(V560G) and the mTORC1/4E-BP1 pathway for KIT(D816V) shows potential for treating mastocytosis.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

